Rankings
▼
Calendar
NTRA Q1 2022 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena
NTRA
Natera, Inc.
$29B
Q1 2022 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$194M
+27.5% YoY
Gross Profit
$91M
46.8% margin
Operating Income
-$137M
-70.6% margin
Net Income
-$139M
-71.4% margin
EPS (Diluted)
$-1.45
QoQ Revenue Growth
+12.2%
Cash Flow
Operating Cash Flow
-$137M
Free Cash Flow
-$153M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$602M
Stockholders' Equity
$542M
Cash & Equivalents
$158M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$194M
$152M
+27.5%
Gross Profit
$91M
$86M
+6.3%
Operating Income
-$137M
-$63M
-117.6%
Net Income
-$139M
-$64M
-117.1%
Revenue Segments
Product
$190M
98%
Licensing and other
$4M
2%
Geographic Segments
United States
$187M
96%
Europe, Middle East, India, Africa
$4M
2%
Asia Pacific and Other
$2M
1%
Americas, excluding U.S.
$741,000
0%
← FY 2022
All Quarters
Q2 2022 →